Intra-articular Hyaluronic Acid Therapy
In 1936, Karl Meyer and associates, while working with patients with rheumatoid arthritis at Columbia University, New York, isolated and characterized the active part of the synovial fluid of the swollen joints. They named the polysaccharide thus isolated hyaluronic acid (HA). HA is a linear polysaccharide that is composed of repeating disaccharide units of glucoronic acid and N-acetylglucosamine.
KeywordsHyaluronic Acid Synovial Fluid Pressure Bandage Repeat Disaccharide Unit Medial Joint Line
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Athanassiou-Metaxa M, Koussi A, Economou M et al (2002) Chemical synoviorthesis with rifampicine and hyaluronic acid in haemophilic children. Haemophilia 8(6):815–816PubMedCrossRefGoogle Scholar
Fernández-Palazzi F, Viso R, Boadas A et al (2002) Intra-articular hyaluronic acid in the treatment of haemophilic chronic arthropathy. Haemophilia 8(3):375–381PubMedCrossRefGoogle Scholar
Wallny T, Brackmann HH, Semper H et al (2000) Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. Clinical, radiological and sonographical assessment. Haemophilia 6(5):566–570PubMedCrossRefGoogle Scholar
Fernández-Palazzi F (1998) Treatment of acute and chronic synovitis by non-surgical means. Haemophilia 4(4):518–523PubMedCrossRefGoogle Scholar